missing translation for 'onlineSavingsMsg'
Learn More

Umeclidinium bromide, MedChemExpress

Product Code. 16487717
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16487717

Brand: Medchem Express HY12100

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.

Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.

Specifications

Chemical Name or Material Umeclidinium bromide
Physical Form Solid
CAS 869113-09-7
Color Off-White
Quantity 5 mg
Purity Grade Notes Research
Molecular Formula C29H34BrNO2
For Use With (Application) COVID-19-immunoregulation
Synonym GSK573719A
Solubility Information DMSO : ≥ 34 mg/mL (66.86 mM)
SMILES OC(C12CC[N+](CC2)(CCOCC3=CC=CC=C3)CC1)(C4=CC=CC=C4)C5=CC=CC=C5.[Br-]
Molecular Weight (g/mol) 508.49
Formula Weight 508.49
Percent Purity 96.01%
Grade Research
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.